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CONSPECTUS: Azanone (1HNO, nitroxyl) shows interesting yet poorly understood
chemical and biological eﬀects. HNO has some overlapping properties with nitric oxide (NO),
sharing its biological reactivity toward heme proteins, thiols, and oxygen. Despite this
similarity, HNO and NO show signiﬁcantly diﬀerent pharmacological eﬀects. The high
reactivity of HNO means that studies must rely on the use of donor molecules such as
trioxodinitrate (Angeli’s salt). It has been suggested that azanone could be an intermediate in
several reactions and that it may be an enzymatically produced signaling molecule. The
inherent diﬃculty in detecting its presence unequivocally prevents evidence from yielding
deﬁnite answers. On the other hand, metalloporphyrins are widely used as chemical models of
heme proteins, providing us with invaluable tools for the study of the coordination chemistry
of small molecules, like NO, CO, and O2. Studies with transition metal porphyrins have shown
diverse mechanistic, kinetic, structural, and reactive aspects related to the formation of nitrosyl
complexes. Porphyrins are also widely used in technical applications, especially when coupled
to a surface, where they can be used as electrochemical gas sensors. Given their versatility, they
have not escaped their role as key players in chemical studies involving HNO.
This Account presents the research performed during the last 10 years in our group concerning azanone reactions with iron,
manganese, and cobalt porphyrins. We begin by describing their HNO trapping capabilities, which result in formation of the
corresponding nitrosyl complexes. Kinetic and mechanistic studies of these reactions show two alternative operating mechanisms:
reaction of the metal center with HNO or with the donor. Moreover, we have also shown that azanone can be stabilized by
coordination to iron porphyrins using electron-attracting substituents attached to the porphyrin ring, which balance the
negatively charged NO¯.
Second, we describe an electrochemical HNO sensing device based on the covalent attachment of a cobalt porphyrin to gold. A
surface eﬀect aﬀects the redox potentials and allows discrimination between HNO and NO. The reaction with the former is fast,
eﬃcient, and selective, lacking spurious signals due to the presence of reactive nitrogen and oxygen species. The sensor is both
biologically compatible and highly sensitive (nanomolar). This time-resolved detection allows kinetic analysis of reactions
producing HNO. The sensor thus oﬀers excellent opportunities to be used in experiments looking for HNO. As examples, we
present studies concerning (a) HNO donation capabilities of new HNO donors as assessed by the sensor, (b) HNO detection as
an intermediate in O atom abstraction to nitrite by phosphines, and (c) NO to HNO interconversion mediated by alcohols and
thiols.
Finally, we brieﬂy discuss the key experiments required to demonstrate endogenous HNO formation to be done in the near
future, involving the in vivo use of the HNO sensing device.
■ INTRODUCTION
Interest in HNO (azanone according to IUPAC; usually
nitroxyl) has increased in the past decade due to its remarkable
chemical properties and increasing biological relevance.1 HNO
displays a unique spin-forbidden acid−base equilibrium1
(1HNO ↔ 3NO− + H+; pKa = 11.4), and is intrinsically
unstable due to a fast dimerization yielding nitrous oxide
(2HNO → H2O + N2O; kdim= 8 × 10
6 M−1 s−1).2 These
properties make handling of HNO diﬃcult, and it must be
produced in situ from HNO donors; this adds to the challenge
of time-resolved direct detection and quantiﬁcation. Several
pharmacological studies have shown that the eﬀects of HNO
are distinct from those of nitric oxide (NO). HNO causes
preferential venous dilation, whereas NO aﬀects both arterial
and venous smooth muscle.3 However, because their signaling
pathways are not completely diﬀerentiated, it could be that
many biological functions that are attributed to NO are really
promoted by HNO. In fact, NO/HNO interconversion is still a
fundamental open question, and providing a deﬁnite answer to
this issue is an extremely diﬃcult task. Evidence for positive
eﬀects of HNO in preventing heart failure were also reported,1
which results in a strong motivation for the development of
HNO prodrugs for therapeutic applications. Last, but not least,
routes for HNO endogenous production have been also
suggested, such as production by nitric oxide synthase (NOS)
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under restrictive conditions,1,4 among other RNOS redox
related reactions.5 Still, evidence for the endogenous formation
of azanone in living organisms has not been reported, possibly
due to the inherent diﬃculties associated with its unequivocal
detection.
In order to understand the chemical biology of azanone, a
better knowledge of its complex reactivity is needed. HNO
biological targets are mainly metal complexes, proteins, thiols,
NO, and dioxygen. Therefore, signiﬁcant overlap with the
reactivity of NO is observed, and predicting the actual fate of
azanone requires careful determination of the rate and products
of each and every reaction. As an example, heme proteins have
been shown to react with HNO and NO in both the Fe(III)
and Fe(II) states,6,7 yielding in the latter case a stable FeIIP−
HNO adduct (P = heme).8 Several studies have been
performed on the reaction of azanone with Mn, Fe, and Co
porphyrins,9−14 showing interesting features concerning the
underlying mechanism, rate, and selectivity. Particularly exciting
is the use of a Co(III) porphyrin immobilized on a gold surface
as an electrochemical method for selective azanone quantiﬁca-
tion, allowing the time-resolved concentration of HNO to be
determined down to the nanomolar level.15
In the past decade several direct HNO detection and
quantiﬁcation methods have emerged (Figure 1).1,16−21
Previously, methods relied on indirect evidence of HNO by
detection of its reaction products, such as N2O. Strategies for
direct detection are diverse: the use of thiols as trapping agents
followed by HPLC analysis;18,22−24 spectroscopic methods
based on HNO reaction with metal complexes,9,11,14,19 such as
ﬂuorescence20,21,25 or reaction with phosphines,17 and even
EPR1,26 and mass spectrometry.16 These sensing techniques
have triggered the study of a number of reactions involving
HNO, under a variety of circumstances (including in living
cells) and with high sensitivity (up to the nanomolar level), and
it can be envisioned that in the future these could be of help in
answering some of the fundamental questions related to the
chemical biology of HNO, such as: is azanone produced
endogenously? If so, how and where is it produced? Are some
of the biological signaling pathways nowadays attributed to NO
due to HNO? Could it be a product of NO interconversion or
is it the other way around? Or both? We hope that answers to
these questions will soon be found along with a greater
appreciation of the chemical and biological importance of
HNO.
It should be noted that E°(NO/3NO¯) = −0.81 V1 and
E°(NO•, H+/HNO) = −0.11 V,2 becoming −0.55 V at pH 7
(all values against NHE). This last value is around the limit for
biological reducing agents. However, it has to be taken into
account that prediction of reaction feasibility by using its ΔE
value only applies under equilibrium, at the pH values and
concentrations at which the reduction potentials were
calculated, and for outer sphere electron transfer mechanisms.
■ HNO/NO− IRON COMPLEXES
{FeNO}n complexes with n = 6, 7, and 8 are key intermediates
in NO and nitrite-reducing enzymes in bacteria and fungi,
which catalyze important processes related to the biogeochem-
ical cycle of nitrogen. {FeNO}n is the notation proposed by
Enemark and Feltham in recognition of the covalent nature of
the M−NO bond, where n stands for the number of electrons
in the metal d and NO π* orbitals.27 By use of a simpliﬁed
limiting approach, the {FeNO}6/7/8 complexes can be described
as an iron(II) center coordinated to NO+, NO•, or NO−/HNO,
respectively. Initially, Enemark and Feltham did not include the
HNO complexes in their formalism since its main goal was to
extend Walsh’s molecular orbital diagrams for triatomic species
to understand the MNO angles in nitrosyl complexes.
However, since HNO complexes are simply protonated NO−
complexes, it seems reasonable to classify them as {MNO}8
complexes.
Recently, an increasing number of reports on {FeNO}8
complexes have contributed to the spectroscopic character-
ization of this initially elusive species, but still much more
investigation is needed to elucidate mechanistic issues. An
interesting example is the catalytic cycle of fungal nitric oxide
reductase (P450nor), which converts NO to N2O via a
Figure 1. HNO detection methods.
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proposed {FeNO}8 intermediate (intermediate I); this then
reacts with NO to generate N2O and the Fe(III) form.
28 The
ﬁrst spectroscopic evidence of the existence of {FeNO}8 heme
model complexes were obtained from spectroelectrochemical
experiments with FeIIPNO (P = TPP and OEP).29,30 The
reaction of [FeIIPNO]− with weak acids was also studied; the
protonated HNO complex was not stable and oxidized back to
the {FeNO}7 complex.30 In the electrocatalytic reduction
involving the water soluble porphyrin [Fe(TSPP)]3−, nitrite is
reduced to ammonia as in the case of nitrite reductases, through
the intermediacy of {FeNO}6−8 species, which were also
proposed in theoretical papers.31
We have focused on using electron-poor porphyrins to
stabilize {FeNO}8 complexes because of their importance in
bioinorganic chemistry and because all previously reported
{FeNO}8 heme models have proved impossible to isolate due
to their susceptibility to oxidation.29,30 The {FeNO}8 complex
[Co(C5H5)2]
+[Fe(TFPPBr8)NO]
− was obtained from reduc-
tion of the {FeNO}7 complex FeII(TFPPBr8)NO
• with
cobaltocene, and according to spectroscopic and theoretical
evidence, its electronic structure was assigned as intermediate
between FeIINO− and FeINO•,32 in contrast with the
predominant FeIINO− character of previous reports of non-
heme {FeNO}8 complexes.33 In fact, biologically relevant non-
heme {FeNO}8 complexes, implied in bacterial NO reductases,
are high-spin with an S = 1 ground state.34 The 15N NMR
spectrum, never reported before for an FeIINO− system,
showed irrefutable evidence of a diamagnetic deprotonated
{MNO}8 complex, with a signal at +790 ppm vs CH3
15NO2, a
value in the upper limit of previously characterized {MNO}8
complexes. The use of electron-withdrawing groups on the
porphyrin ring enhanced stability with respect to earlier studied
systems. The reduction of the {FeNO}7 system showed a
second reversible wave in the CV, and this second reduction
product, [Fe(TFPPBr8)NO]
2−, was also characterized by FTIR
and UV−vis spectra in solution.35 Although, in principle, a
somewhat larger degree of reduction on NO is expected, the
N−O stretching IR band shifted from 1550 to 1590 cm−1 (the
opposite trend would be expected for augmented electron
density on the FeNO moiety). This increase in the N−O
stretching frequency was predicted by DFT calculations not for
the low spin complex (S =1/2), but for the intermediate or high
spin states (S = 3/2 or 5/2). The Fe−N−O angle in the
calculated structures of these states is similar to the {FeNO}7
complex; this and the higher N−O stretching frequency
suggested the structure [{FeNO}7(TFPPBr8
4−)]2− for the
doubly reduced product.
While the perhalogenated porphyrin resulted an appropriate
platform to stabilize the FeNO− moiety, attempts to protonate
[Fe(TFPPBr8)NO]
− to give the expected Fe(P)HNO complex
were unsuccessful, yielding instead the {FeNO}7 complex.
Although isolated iron porphyrins seemed unable to present
stable protonated {FeHNO}8 complexes, a fairly stable
{RuHNO}8 complex, [Ru(TTP)(HNO)(1-MeIm)], was ob-
tained without the support of a protein environment,
suggesting an additional source of stabilization of the HNO−
porphyrin moiety.36 Note that the only well characterized heme
{FeHNO}8 complexes known to date were prepared in the
myoglobin active site and with human, soy, and clam
hemoglobin. In these systems, the distal residues may play a
crucial role in the stabilization of the protonated adduct.8,37
Interestingly, recent results show the use of a picket-fence
porphyrin, which allows formation of the protonated Fe(P)-
HNO complex by reaction of the NO− complex with acetic
acid.38 The HNO complex also decomposes to a {FeNO}7
complex but at a slower rate (90% after 20 h). However, the
underlying reason for the instability of the {FeHNO}8 complex
relative to the disproportion to {FeNO}7 and H2 is not clear.
The non-heme {FeHNO}8 complex [Fe(CN)5(HNO)]
3− has
been reported as a stable FeIIHNO complex in aqueous
solutions;39 in the pentacyano platform, we can neither invoke
the supplied stabilization by amino acids as in the protein
complexes nor the steric protection provided by the bulky
substituents in the picket fence adduct. Clearly there are other
factors inﬂuencing the stability of the {FeHNO}8 moiety, for
example, stabilization through hydrogen bonds with the
solvent. Figure 2 summarizes the stable FeHNO complexes
reported so far.
■ HNO TRAPPING BY METALLOPORPHYRINS
The reactions of HNO with metalloporphyrins (MP) of iron,
manganese, and cobalt were interesting targets for investigation
due to the reactivity of HNO and NO toward heme proteins,
and the many known reactions of NO with metalloporphyrins
forming stable ferrous nitrosyl adducts.9,10,15 The interactions
of the HNO donors sodium trioxodinitrate (AS, Angeli’s salt)
and toluenesulfohydroxamic acid (TSHA, a Piloty’s acid (PA)
derivative) with Fe(III)P (both in water and in organic media)
were studied.9 As expected, we observed eﬃcient conversion to
the corresponding nitrosyl adduct, {FePNO}7. The reaction
was easily followed by UV−vis spectroscopy, despite the slight
spectral changes. Following the observed success, we tested
Mn(III)P, which, as their iron analogues, showed eﬃcient
conversion to the corresponding {MnNO}6 adducts upon
exposure to both HNO donors. Interestingly, MnPNO showed
a signiﬁcant shift in the Soret band (>30 nm) with respect to
the MnP reactant, providing the foundations for a colorimetric
HNO detection assay.10
Figure 2. Diﬀerent platforms for stabilizing NO−/HNO iron complexes.
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Our analysis in the reaction kinetics of these systems reveals
two diﬀerent behaviors related to the rate of nitrosyl−
porphyrin production and the stoichiometric donor/porphyrin
ratio required to convert Fe(III)/Mn(III) porphyrins. When
negatively charged porphyrins reacted with AS (pH 7) or PA
(pH 10), a large excess of donor was required to drive the
reaction to completion (see Figure 3). Equimolar ratios led to
half-lives on the order of 100 min. In contrast, positively
charged porphyrins (TEPyP) used in an equimolar ratio went
to completion with half-lives of seconds.
A direct porphyrin−donor interaction is suggested because
the eﬀective nitrosyl porphyrin formation rate by far exceeds
the donor spontaneous decomposition, the reaction is ﬁrst
order dependent on donor concentration, and these porphyrins
accelerate donor decomposition. For slower reactions that do
not show a linear rate vs donor concentration relationship, the
expected spontaneous generation by the donor and subsequent
azanone reaction with the porphyrin was assumed to be the
operative mechanism.
By measuring the nitrosyl formation rate, d[MPNO]/dt, as a
function of initial donor concentration, we determined the
porphyrin−donor association bimolecular rate constants
(konDonor) for the fast cases or the porphyrin−HNO association
bimolecular rate constants (konHNO) for the slow cases (see
Figure 4). The overall mechanism is presented in Scheme 1.
During the past decade, we have determined the rates for the
reactions of the HNO donors AS and TSHA with several water-
soluble Mn and Fe porphyrins diﬀering in their total peripheral
charge (positive, neutral, or negative) and redox potentials
(reducing, that is, with E° < 0 mV, or oxidizing, with E° > 0
mV). These results are summarized in Figure 4.
The results presented in Figure 4 show that for all MnP the
same konHNO values are obtained either with AS and TSHA,
while a narrow distribution of values is also obtained for
konDonor. Considering the redox potential, it is clear that those
MnP showing a positive redox potential (>100 mV), accelerate
donor decomposition, despite their peripheral charge. Con-
versely, MnP complexes showing a negative redox potential
(less than −160 mV) trap free HNO.41 DFT studies suggest
that the catalytic eﬀect can be understood either in terms of a
redox reaction, which results in reduced porphyrin and oxidized
donor followed by rapid decomposition to NO and
combination to yield a nitrosyl complex (MPNO), or by direct
Figure 3. Absorbance, λmax, corresponding to the peak position of each
nitrosyl complex vs time plot, for the reaction of three MnIIIP (1 ×
10−5 M) with Angeli’s salt (AS; 5 × 10−5 M) in phosphate buﬀer (0.1
M) at 25 °C (reduction potentials are indicated in the plot).
Figure 4. Values of kon (M
−1 s−1) for HNO trapping (black, left axis) and donor trapping (red, right axis) by Fe and Mn porphyrins.
Metalloporphyrins with E < −100 mV40 trap HNO, while those with E > −100 mV40 react with the donor. Porphyrins with E ≈ −100 mV40 react by
both pathways.
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coordination of the donor to the metal that promotes X−NO
bond breakage.41
Another particularly interesting point that arises as a global
picture concerns the fact that even if myoglobin−HNO adducts
and FePNO− complexes have been obtained, no reaction is
observed with either PA or AS for any of the studied iron
porphyrins in the ferrous state. Thus, while NO is promiscuous
for both Fe(III) and Fe(II), HNO is selective for ferric
porphyrins. The same observation was made for Mn
porphyrins. Only Mn(III) reacts with azanone. CoP behaves
similar to MnP: Co(III)P eﬃciently reacts with azanone donors
to produce the corresponding nitrosyl, being inert to NO, and
Co(II)P reacts with NO but not with HNO. According to our
data and previous works, it is clear that AS or PA (or HNO)
does not react with ferrous porphyrins, or that the ferrous−
HNO complex, if established, is not stable and does not
accumulate to allow spectroscopic detection. Although we do
not know the reason underlying this behavior, it seems likely
that the potential ferrous−HNO complex is too labile (i.e.,
HNO dissociation exceeds the rate of HNO binding), and thus
no complex is observed without the presence of the protein
matrix to stabilize it (as seen in several globins). The diﬀerential
reactive behavior with NO/HNO for each MP is summarized
in Scheme 2. It clearly shows that while Mn and Co porphyrins
can distinguish between NO and HNO based on their redox
states, Fe(III) analogues react with both species in both redox
states and cannot be used for discrimination purposes.
Combining all available data, it is possible to perform a
comparative analysis for the reaction kinetics of NO and HNO
with metalloporphyrins and heme proteins (Table 1). The
results shows that HNO association rate constants to M(III)P
and ferric heme proteins fall in the 5 × 104 to 1 × 106 M−1 s−1
range, being similar to the values obtained for NO binding to
ferric hemes. These rates are ca. 1000 times smaller than those
for NO (or CO) binding to ferrous hemes. This can be
explained by the fact that in ferric hemes the ligand association
rate is limited by water release, while in ferrous hemes, the
coordination site is empty.
Scheme 1. Two Diﬀerent Reaction Mechanisms between
Metalloporphyrins and Common HNO Donorsa
aIn blue is the accelerated mechanism, where the porphyrin−donor
association bimolecular rate constants were measured. In red is the
direct reaction mechanism, where the ﬁrst step is the donor
decomposition to generate HNO and HNO reacts with the porphyrin
in a second step.
Scheme 2. HNO versus NO Reactivity of Mn, Co, and Fe Porphyrins and UV-Vis Shifts of the Soret Bands for the
Corresponding M(P)NO Products1,9,10,12
Table 1. HNO and NO Binding Constant to Ferrous and
Ferric Heme Proteins and Other Heme Models
target E1/2 vs NHE (mV) reactant kon (M
−1 s−1) ref
FeIIIMP11 −280 HNO 3.1 × 104 11
NO 1.1 × 106 42
[FeIIITSPP]3− +23 NO 4.5 × 105 43
[FeIITSPP]4− −300 NO 1.5 × 109 43
Cyt-c(FeIII) +250 HNO 4 × 104 44
catalase(FeIII) −226 HNO 3 × 105 44
metMb(FeIII) +120 HNO 8 × 105 44
Mb(MnIII) −320 HNO 3.4 × 105 14
Mb(FeII) −430 HNO 1.4 × 104 45
NO 2.0 × 107 46
O2 HNO 3 × 10
3 44
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■ TIME-RESOLVED SELECTIVE ELECTROCHEMICAL
DETECTION OF HNO
In vivo measurement of HNO requires a small device
(millimeter or smaller) capable of functioning in aqueous
solution. Using our knowledge of the chemistry of HNO with
metalloporphyrins and due to their widespread use in
electrochemical applications, we have developed an electro-
chemical HNO sensor.15 After several preliminary tests in
solution, a cobalt (II) porphyrin provided with four sulfur
anchors [Co(P)], which can be covalently immobilized on gold
electrodes, was selected (Figure 5). The electrode showed good
selectivity toward azanone, being able to form stable CoIII(P)-
NO− adducts through the reaction of CoIII with HNO donors.
The remaining surface was covered with cysteamine
(HSCH2CH2NH2), rendering it inert to NO.
In the amperometric detection of HNO (Figure 5), the
electrode resting state is set to 0.8 V, where the porphyrin is
stable in the CoIII(P) state and no current is observed. The
presence of HNO results in formation of the CoIII(P)NO−
adduct, which under these conditions is oxidized. The resulting
CoIII(P)NO releases NO completing the cycle. The current
intensity is proportional to the amount of HNO that binds to
Co(P). Figure 6A shows the current intensity versus time plots
after the addition of the HNO donor. A few seconds after the
addition, a steep rise in the signal is observed; the maximum
increases with donor concentration. A slow decay is then
observed; similar to the donor spontaneous decomposition
rate. A kinetic model was developed to allow us to analyze the
current intensity versus time proﬁles. This model assumes the
presence of a thin diﬀusion layer close to the electrode surface
allowing us to directly relate the current intensity with the bulk
HNO concentration through a system-dependent eﬀective rate.
This scheme can be used to determine the kinetics of HNO-
related reactions as shown in the next section. Figure 6b shows
simulated and measured current intensity showing the excellent
agreement of our kinetic model.
To determine the electrode sensitivity and dynamic range,
we performed an independent estimation of bulk HNO
concentration and its relation to the observed peak current
intensity (ΔC). We estimated the bulk HNO concentration at
its peak by measuring the Mn nitrosyl porphyrin production
rate under the same conditions as those used with the electrode
and also using a simpliﬁed kinetic model.
Figure 7 shows the peak current (ΔC) as a function of bulk
HNO concentration, showing that the electrode has a linear
response in the 1 nM to 1 μM range allowing us to quantify
azanone at nanomolar concentrations. An analysis of the
electrode response in the presence of other reactive nitrogen
and oxygen species (RNOS) in a complex biological media
showed that although the electrode response is aﬀected, it can
still detect HNO at nanomolar levels. The most dramatic eﬀect
Figure 5. Mechanism of electrochemical HNO detection by Co(P)
covalently attached to a gold surface.
Figure 6. (A) Current intensity versus time plots for Co(P) modiﬁed electrode after the addition of increasing concentrations of HNO donor (AS).
(B) Measured and simulated current vs time (black and red, respectively, right axis), and simulated HNO concentration at the same donor
concentration (0.34 μM, green, left axis). A slight delay is observed in the signal.
Figure 7. Electrode calibration of the current intensity as described in
ref 12. The HNO concentration range is ca. 1−20 nM. Inset: The
same as above for HNO concentration range of ca. 1−150 nM.
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on the electrode signal is due to the presence of oxygen. The
electrode response in cell culture with intact cells and with
lysed cells is only minimally altered.
■ APPLICATIONS OF THE HNO-SENSING
ELECTRODE
The sensor allows us to systematically probe for the presence of
HNO in practically any chemical or biological reaction. Our
ﬁrst application was to use it to analyze HNO donation for a set
of N-hydroxy-benzenesulfonamides, that is, PA-like derivatives
that include electron-withdrawing and -donating substituents
(Scheme 3).
We measured the peak current intensity vs pH (Figure 8A),
which allowed determination of the optimal pH range of HNO
production.47 Kinetic measurement of the intensity (propor-
tional to HNO concentration) versus time plots yielded the
donor decomposition rate constant (Figure 8B).15
Comparison of the properties for all donors, in terms of rate
and pH range of HNO release (Table 2), showed that
signiﬁcant diﬀerences are observed and that the ﬂuorinated and
triiso derivatives release HNO c.a. 10 times faster than PA, and
in a physiologically compatible pH range.
The second opportunity to test the electrode performance
was in collaboration with Ford’s group48 in the context of
oxygen atom transfer reaction studies from nitrite to a water-
soluble phosphine (tppts) and biological thiols, mediated by
FeIIITSPP in weakly acidic media (pH = 5.81). The results,
interpreted in Scheme 4, show that when the phosphine is the
oxygen atom acceptor, the ferrous nitrosyl−porphyrin inter-
mediate becomes protonated and releases HNO, generating an
electrode signal.
Interestingly, the presence of the phosphine is necessary for
HNO production, since the use of thiol as oxygen acceptors
shows neither any electrode signal nor N2O production.
Generation of HNO from nitrosyl porphyrins has not been
reported previously under any circumstances. These results not
only underscore the utility of the azanone sensing device for the
elucidation of reaction mechanisms involving reactive nitrogen
species, where HNO is a likely intermediate, but also draw our
attention to the potential physiological production of azanone
derived from protein based {FeNO}7 complexes, such as that
proposed for the NOS enzyme.
The observation of HNO production from ferrous nitrosyl
complexes, together with studies from Filipovic et al. showing
Figure 8. (left) pH versus current intensity for Me−PA. The current can be converted to HNO concentration as previously described.15 (right)
Time-resolved electrode response for a 3.4 μM solution of Me−PA (black) and simulated (red).
Scheme 3. HNO Releasing N-Hydroxy-benzenesulfonamide
Derivatives
Table 2. Rate Constants for the Decomposition of Piloty’s
Acid Derivatives
product rate constant (k, s−1)a
decomposition
pHb
HNO donation
pHc
Me−PA (1.91 ± 0.09) × 10−4 9 10.3
NO2−PA (3.51 ± 0.02) × 10−4 5 5.5
F−PA (1.95 ± 0.01) × 10−3 3 3.8
Triiso−PA (4.97 ± 0.02) × 10−3 3 5.0
OMe−PA (3.53 ± 0.07) × 10−4 5 5.9
(NO2−CF3)−
PA
(6.32 ± 0.08) × 10−4 −1 d
aRate constant at the decomposition pH. bpH at which decomposition
starts to be observed by UV−visible or NMR spectroscopy. cInﬂection
point for the current vs pH curves. dNot measured.
Scheme 4. HNO Formation by Reaction of Fe(TSPP),
Nitrite, and Phosphines (P)
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that both the soluble and iron coordinated “smallest”
nitrosothiol HSNO, produced either through radical combina-
tion of NO and HS• or H2S and a pentacyano {FeNO}
6
complex, yield azanone,5,49 prompted us to analyze the NO
reaction with biologically compatible hydrogen atom donors
and reductants in order to determine their possible role as
chemical HNO sources.
Our results show that hydroxy/keto bearing reductants, such
as ascorbic acid and hydroquinone, and phenolic compounds
like the amino acid tyrosine react with NO in an eﬀective
bimolecular reaction to yield HNO (Scheme 5). This is shown
by the characteristic current vs time plot and NO/reductant
concentration-dependent peak intensity determined with the
HNO selective electrode. Mechanistic analysis combining EPR,
MS, and DFT calculations strongly suggests that the reductants
are able to produce HNO from NO through a mechanism
involving indirect hydrogen atom transfer.
Related to the above mentioned results, we have recently
shown, in collaboration with several groups, that NO reacts
with H2S at a fast rate by nucleophilic attack of HS
− to NO,
yielding HNO (Scheme 5).50 In this context, biological
experiments showed that HNO is a potent activator of
TRPA1 ion channel through the formation of disulﬁde bonds
and that joint neuronal production of NO and H2S results in
channel activation. These data thus provide strong support of a
chemical route to biological azanone production resulting in a
speciﬁc physiological response.50
In summary, the presented examples show how the azanone
selective electrode has become an invaluable tool to probe the
chemical biology of HNO, allowing us to conﬁrm its presence
in several physiologically relevant reactions. These results,
together with those of our colleagues,49,51,52 emphasize the
potential of reactions involving NO and HNO endogenous
sources and make a strong case for further studies on their
physiological eﬀects, particularly in relation to the diﬀerences
and similarities with those of NO and other potential
biochemical azanone sources like NO2
−, hydroxylamine, urea,
cyanamide, etc.1,53 Finally, although in vivo endogenous
production of HNO has not been unequivocally established,
the presented data suggest novel situations to be investigated.
■ SUMMARY AND PERSPECTIVES
After 10 years of research that began with the simple idea of
producing ferrous nitrosyl complexes {FeNO}7 through the
reaction of ferric porphyrins with derived from spontaneous
decomposition of its donors as an alternative to the more
traditional route involving ferrous porphyrins and NO, we have
traveled a path that has taken us through several (bio)inorganic
research ﬁelds related to NO and HNO chemical biology. We
have contributed to a deeper understanding of metal nitrosyl
complexes, showing how the porphyrin substituents can
stabilize extreme redox states like those of the {FeNO}8
complexes, as well as characterizing the reactivity of Fe, Mn,
and Co porphyrins with HNO and its donors, contributing also
to their improvement and their versatility. Most importantly, all
the knowledge gained from the studies of nitrosyl−metal-
porphyrins has allowed us to develop a time-resolved HNO
sensing device that, together with a battery of methods
established in the past decade (Figure 1), has changed the
paradigm of HNO chemistry and biology from a minor role of
an elusive “NO-like” molecule to the center stage as a potential
relevant intermediate in RNOS chemistry, a biological
mediator, and a therapeutic agent. Fruits of this new-view are
the central roles of HNO in several physiologically compatible
reactions.
The future of HNO chemical biology is wide and deep; its
role as chemical intermediate and its reactivity and end-
products in many reactions are still not fully understood. Its
biological role as a messenger molecule with its own pattern of
eﬀects in diﬀerent physio- and pathological states is only
beginning to emerge and is drawing the attention of an
increasing number of biomedical researchers. Not to be
forgotten is the potential involvement of HNO and both
{FeHNO}8 and {FeNO}8 complexes in NO-reducing enzymes,
including those related to the nitrogen cycle in the context of
plants and microbial metabolism, a ﬁeld that is as yet almost
completely overlooked.54 Lastly, the development of HNO
donors as prodrugs requires as key evidence the detection of
the active compound “HNO” in vivo at the site of action. Our
electrode oﬀers, in our view, the best perspective to become the
reference method for these types of studies, and preliminary
results show that it is able to detect azanone inside the left
ventricle of a living rat after donor injection in a distant artery.
This capability will be crucial in order to demonstrate HNO
endogenous production and its biochemical role. Further
research in this utmost relevant issue is ongoing and awaited
with great expectations. The somewhat ignored brother of NO
is growing and getting ready for the “big leagues”.
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